Bradley J. Gardiner - Concepedia

Author

Bradley J. Gardiner

Also Known As

B J Gardiner, B. J. Gardiner, B.J. Gardiner, Benjamin Gardiner, Brad Gardiner, Bradley Gardiner, Bradley J Gardiner, Bradley J. Gardiner, Lyn-Li Lim, Sadid Khan

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Monash University The University of Melbourne Alfred Health Tufts University Tufts Medical Center

About

Bradley J. Gardiner is an author at Monash University specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	219
2	Microbiology	4	4	118
3	Health Sciences	2	2	74
4	Immunology	1	1	27
5	Pathology	1	1	22

Bradley J. Gardiner

Publications

805

Citations

H-Index

Page 1

	Year	Citations
Clinical and Microbiological Characteristics of Eggerthella lenta Bacteremia Bradley J. Gardiner, Alex Tai, Despina Kotsanas, Journal of Clinical Microbiology	2014	153
Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis? Bradley J. Gardiner, Andrew A. Mahony, Andrew G. Ellis, Clinical Infectious Diseases	2013	102
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients Bradley J. Gardiner, Natalie E. Nierenberg, Jennifer Chow, Clinical Infectious Diseases	2018	90
Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unit Jason A. Trubiano, Bradley J. Gardiner, Jason C. Kwong, European Journal of Gastroenterology & Hepatology Antimicrobial SusceptibilityIntensive Care UnitAntibioticsAdjunctive FmtHealthcare-associated Infection	2012	65
Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs: Figure 1. M. Lindsay Grayson, Nenad Maćešić, Janine M. Trevillyan, Clinical Infectious Diseases Veterinary ResearchAntimicrobial ChemotherapyPharmacokinetic AnalysisFigure 1Drug Resistance	2015	55
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients Bradley J. Gardiner, Jennifer Chow, Lori Lyn Price, Clinical Infectious Diseases	2017	51
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial James McMahon, Jillian S. Y. Lau, Anna Coldham, EClinicalMedicine Covid-19 PandemicAntiviral TherapyCovid-19 EpidemiologyCovid-19Randomised Placebo-controlled Trial	2022	46
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis Nathaniel J. Rhodes, Bradley J. Gardiner, Michael Neely, Journal of Antimicrobial Chemotherapy	2015	41
Evaluation of Quantiferon®‐Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients Bradley J. Gardiner, Sue J. Lee, Y. Cristiano, Transplant Infectious Disease	2020	28
Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case–control study Bradley J. Gardiner, Erica M. Haas, Rosemary C Bailey, Rheumatology International RheumatologyViral PersistenceAutoimmune DiseaseCase–control StudyLatent Cytomegalovirus Infection	2019	27

Page 1